Rehmann Capital Advisory Group Purchases Shares of 861 CME Group Inc. $CME

Rehmann Capital Advisory Group purchased a new stake in CME Group Inc. (NASDAQ:CME) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 861 shares of the financial services provider’s stock, valued at approximately $237,000.

A number of other hedge funds have also recently bought and sold shares of CME. GQG Partners LLC raised its stake in shares of CME Group by 7,676.3% in the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock valued at $584,975,000 after buying an additional 2,176,685 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of CME Group by 370.5% in the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock valued at $704,068,000 after buying an additional 2,089,935 shares in the last quarter. Nuveen LLC acquired a new position in shares of CME Group in the 1st quarter valued at $218,842,000. Alliancebernstein L.P. raised its stake in shares of CME Group by 185.5% in the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock valued at $330,182,000 after buying an additional 808,740 shares in the last quarter. Finally, Egerton Capital UK LLP raised its stake in shares of CME Group by 79.4% in the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock valued at $459,003,000 after buying an additional 765,773 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Trading Up 0.2%

Shares of CME Group stock opened at $269.54 on Friday. The stock has a market capitalization of $97.14 billion, a P/E ratio of 26.12, a price-to-earnings-growth ratio of 6.18 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a 50-day simple moving average of $266.47 and a 200 day simple moving average of $271.67. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s revenue for the quarter was down 3.0% on a year-over-year basis. During the same quarter last year, the company posted $2.68 EPS. Research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Weiss Ratings restated a “buy (b)” rating on shares of CME Group in a research note on Friday. Oppenheimer increased their price objective on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Wall Street Zen cut shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Jefferies Financial Group dropped their price objective on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research note on Friday, October 10th. Finally, Morgan Stanley increased their price objective on shares of CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a research note on Thursday. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $284.53.

Insider Activity at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William R. Shepard acquired 262 shares of the stock in a transaction on Thursday, September 25th. The stock was bought at an average price of $265.19 per share, with a total value of $69,479.78. Following the transaction, the director directly owned 258,459 shares in the company, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.